Curis
CRIS
#11031
Rank
โ‚น0.56 B
Marketcap
โ‚น85.06
Share price
6.65%
Change (1 day)
-26.74%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2023 (TTM): -โ‚น820.62

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น1,334. In 2022 the company made an earnings per share (EPS) of -โ‚น1,145 a decrease over its 2021 EPS that were of -โ‚น938.32.

EPS history for Curis from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น820.62-28.31%
2022-โ‚น1,14522%
2021-โ‚น938.32-25.37%
2020-โ‚น1,257-30.93%
2019-โ‚น1,820-2.02%
2018-โ‚น1,858-37.38%
2017-โ‚น2,967-29.73%
2016-โ‚น4,222-10%
2015-โ‚น4,692138.1%
2014-โ‚น1,97040%
2013-โ‚น1,407-25%
2012-โ‚น1,87766.67%
2011-โ‚น1,126-850%
2010โ‚น150.13-114.29%
2009-โ‚น1,051-26.07%
2008-โ‚น1,422-26.28%
2007-โ‚น1,9288.44%
2006-โ‚น1,778-32.68%
2005-โ‚น2,641-3.76%
2004-โ‚น2,74562.95%
2003-โ‚น1,684-93.86%
2002-โ‚น27,42339.5%
2001-โ‚น19,658

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น71.31-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น424.12-131.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น33.78-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น324.66-124.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น408.17-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น298.39-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚น322.78-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA